SCHEMBL28501694

SCHEMBL28501694

N#CC[C@H]1CN(c2nc(Cl)nc3c2CCNC3)CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28501696 1.00 — —
SCHEMBL23841610 0.91 — —
SCHEMBL23275954 0.84 ADRB1 (0.32) —
SCHEMBL28496970 0.81 STK3 (0.31) —
SCHEMBL19964148 0.81 KRAS (0.35) —
SCHEMBL29116617 0.80 KRAS (0.31) —
SCHEMBL28500433 0.80 KRAS (0.31) —
SCHEMBL23075033 0.78 C5AR1 (0.42) —
SCHEMBL23074821 0.78 C5AR1 (0.42) —
SCHEMBL23074902 0.78 C5AR1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111989321-A KRAS G12C inhibitors 米拉蒂治疗股份有限公司 2020-11-24 — — CN disclosed
Send feedback